Search Results
69 Results for 'Differentiation'
PAGE 3 OF 3
Technology
Expansion Of Hpsc-Derived Granulocytic And Lymphoid Progenitors With Um171
The present invention provides methods of amplifying or expanding CD34+CD43+CD45+CD41loCD235+/− hematopoietic progenitor cells enriched in granulocytic progenitors (G-CFCs). In another embodiment, t...
Learn More
Learn More
Igor Slukvin, Walatta-Tseyon Mesquitta | P190044US02
Technology
Generation Of Hematopoietic Progenitor Cells From Human Pluripotent Stem Cells
Methods for generating and using hematopoietic progenitor cells are described.
Learn More
Learn More
James Thomson, Jue Zhang | P180326US02
Technology
Chemically Defined Differentiation Protocol For Pericyte Differentiation From Pluripotent Stem Cells
The present invention provides methods of differentiating pericytes from pluripotent stem cells comprising culturing steps in chemically defined culture medium. A population of exogenously derived per...
Learn More
Learn More
William Murphy, William Daly, Cheryl Soref, Elizabeth Torr, Elizabeth Aisenbrey, Hunter Johnson | P180159US02
Technology
Artificial Transcription Factors and Uses Thereof
Transcription factor expression can profoundly alter the transcriptional dynamics of a cell, even inducing the transition to a new cell fate. Four transcription factors – Oct4, Sox2, Klf4, and c-Myc...
Learn More
Learn More
Aseem Ansari, Asuka Eguchi | P160383US02
Technology
Improved Method for Generating Epicardium from Human Pluripotent Stem Cells
Given their developmental importance and therapeutic potential, epicardial cells and epicardium-derived cells are a promising progenitor source to restore functional vasculature, maintain cardiomyocyt...
Learn More
Learn More
Sean Palecek, Xiaoping Bao, Xiaojun Lian | P150192US02
Technology
Derivation of Human Microglia from Pluripotent Stem Cells
Microglia act as the first and main form of active immune defense in the central nervous system. They are the primary source of brain cytokines and have been implicated in chronic neuroinflammation (e...
Learn More
Learn More
James Thomson, Nicholas Propson, Michael Schwartz, Zhonggang Hou, Gene Uenishi, Igor Slukvin, William Murphy, Jue Zhang | P140410US02
Technology
Xeno-Free Protocol for Generating Endothelial Cells from Human Pluripotent Stem Cells
Endothelial cells (ECs) are vital to blood vessel formation. Generating ECs from human pluripotent stem cells (hPSCs) has powerful potential for cardiovascular health and drug development. However, st...
Learn More
Learn More
James Thomson, Jue Zhang | P140372US02
Technology
Albumin-Free Protocol Cuts Cost, Supports Large-Scale Cardiomyocyte Production
Generating cardiovascular cells from pluripotent stem cells holds profound promise for research and therapy, and the past 10 years have witnessed rapid methodological advances for creating de novo hum...
Learn More
Learn More
Sean Palecek, Xiaojun Lian, Xiaoping Bao | P150011US02
Technology
Generating Human Heart Cells via Lineage Reprogramming
Converting one type of cell to another with no intermediate pluripotent stage is called lineage reprogramming. The method has been used to ‘reprogram’ mouse fibroblasts to cardiomyocytes (heart mu...
Learn More
Learn More
Timothy Kamp, Pratik Lalit | P140116US02
Technology
Controlling the Formation of Stem Cell Colonies with Tailored SAM Array
The substrate on which cells are cultured is key to successful growth and tissue generation. For example, it has been shown that attachment to a substrate by human embryonic stem cells influences whet...
Learn More
Learn More
William Murphy, Angela Xie | P150062US01
Technology
Generating Oligodendrocytes from Human Embryonic Stem Cells
Oligodendrocytes are a type of brain cell in the central nervous system that produces myelin, a fatty substance that wraps around and insulates neurons. These myelin ‘sheaths’ help conduct nerve i...
Learn More
Learn More
Su-Chun Zhang, Baoyang Hu, Zhong-wei Du | P07394US
Technology
Generating Vasculogenic Cell Populations from Human Stem Cells
Human pluripotent stem cells (hPSCs), either embryonic or induced, provide access to the earliest stages of human development. They also offer a starting point for deriving large numbers of vasculogen...
Learn More
Learn More
Igor Slukvin, Akhilesh Kumar | P130364US02
Technology
Generating Endothelial Cells from Human Pluripotent Stem Cells
Endothelial cells derived from human pluripotent stem cells (hPSCs) hold incredible potential for human health, for example, in the engineering of new blood vessels, heart regeneration and screening f...
Learn More
Learn More
Sean Palecek, Xiaojun Lian, Xiaoping Bao | P130110US02
Technology
Xenogen-Free Culture Medium for Stem Cells
With the advent of human pluripotent stem cell technologies, endothelial and blood lineage (hematopoietic) cells can be produced in vitro for functional studies and therapies. Efficient differentiatio...
Learn More
Learn More
Igor Slukvin, Gene Uenishi | P130178US02
Technology
Investigating Cell-Surface Interactions via Chemical Array
How and why precursor cells differentiate into tissue-specific cell types involves a complex interplay of signals and remains a rich topic of investigation. Outside of the body, for example, certain s...
Learn More
Learn More
William Murphy, Justin Koepsel | P120126US01
Technology
Method of Forming Mesenchymal Stem Cells from Embryonic Stem Cells
Mesenchymal stem cells (MSCs) are precursors to mesenchymal tissues, such as bone, dental tissue, cartilage, tendon, bone marrow stroma, hematopoietic lineages, and muscle. Bone marrow is a useful sou...
Learn More
Learn More
John Wesley Pike, Nirupama Pike | P04247US
Technology
Method of Forming Dendritic Cells from Embryonic Stem Cells
Dendritic cells are used as a base for vaccines and in the study of antigen processing within the human body. However, obtaining large quantities of the cells, which are generated in bone marrow, is l...
Learn More
Learn More
Igor Slukvin, James Thomson, Maksym Vodyanyk, Maryna Gumenyuk | P04434US
Technology
Differentiation of Stem Cells to Endoderm and Pancreatic Cells
Type I diabetes, one of the most common autoimmune diseases in humans, is caused by destruction of pancreatic islet beta cells. Although its symptoms can be controlled, the disease is irreversible. Tr...
Learn More
Learn More
Jon Odorico, Brenda Kahan, Nathan Treff | P04361US
Technology
Multipotent Lymphohematopoietic Progenitor Cells
Human embryonic stem (hES) cells have the potential to provide a source of specific cell types for research and ultimately, for therapeutic transplantation into humans.
Learn More
Learn More
Igor Slukvin, Maksym Vodyanyk, James Thomson | P06082US